SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending as the software sector navigates a significant sell-off driven by "AI fear," sparking intense community debate on whether AI will disrupt or enhance the enterprise giant. Despite news of workforce adjustments and a new government contract, many investors are frustrated by ongoing price declines, viewing it as an oversold opportunity potentially exacerbated by market manipulation.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is buzzing with conversation after its recent financial update, which showcased impressive membership growth and an optimistic 2026 outlook, fueling bullish enthusiasm despite concerns over a quarterly performance miss and ongoing uncertainty surrounding broader healthcare policy.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending due to mixed community reactions following its Q4 earnings report, which showed a beat on adjusted EPS but fueled ongoing concerns about revenue growth and increasing debt. The community is sharply divided between those who see a value opportunity amidst its current valuation and others drawing negative parallels to the broader fintech sector and companies like PayPal.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is at a pivotal moment as its Q4 earnings report is highly anticipated, with the community actively debating whether the recent significant sell-off presents a buying opportunity. Despite broader software sector concerns and increased competition, many highlight Datadog's critical role in monitoring AI-driven cloud infrastructure and its strong customer relationships, while some analysts have adjusted price targets reflecting mixed expectations for performance amidst a valuation reset.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia Technologies is trending following strong Q4 earnings, optimistic FY2026 guidance, and reaffirmed targets for profitability by 2027, with the community actively discussing its potential as the 'Amazon of Africa' amidst bullish analyst coverage.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is trending due to its strong Q4 earnings beat and robust subscriber growth, alongside recent premium subscription price increases. The community is widely debating if these positive catalysts, coupled with new AI features and video content, can reverse the stock's recent downtrend and its perceived correlation with Netflix's performance, as many consider it oversold.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Cola is trending following its earnings report, which revealed a revenue miss primarily due to weak North American demand, sparking community discussions about its recent rally and overbought conditions despite an earnings per share beat and strong performance in the broader consumer staples sector.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending as investors digest mixed Phase 2b results for its alopecia areata drug, with community discussion focused on the significance of efficacy data achieved after excluding some patients and the drug's strong safety profile, alongside ongoing speculation about a potential Lilly settlement.

S&P Global, Inc. engages in the provision of transparent and independent ratings, benchmarks, analytics, and data to the capital and commodity markets worldwide. It operates through the following segments: Market Intelligence, Ratings, Commodity Insights, Mobility, Indices, and Engineering Solutions. The Market Intelligence segment provides multi-asset-class data and analytics integrated with purpose-built workflow solutions. The Ratings segment is involved in credit ratings, research, and analytics, offering investors and other market participants information, ratings, and benchmarks. The Commodity Insights segment focuses on information and benchmark prices for the commodity and energy markets. The Mobility segment offers solutions serving the full automotive value chain including vehicle manufacturers, automotive suppliers, mobility service providers, retailers, consumers, and finance and insurance companies. The Engineering Solutions segment engages in advanced knowledge discovery technologies, research tools, and software-based engineering decision engines to advance innovation, maximize productivity, improve quality, and reduce risk. The company was founded by James H. McGraw and John A. Hill in 1917 and is headquartered in New York, NY.

S&P Global Inc

S&P Global is trending as its latest guidance signaled slower growth and missed analyst estimates, fueling community discussion amidst broader concerns that powerful new AI models, such as Anthropic's Claude Opus 4.6, could significantly disrupt the financial data and analytics sector, though many also view the sharp sell-off as an overreaction and a buying opportunity.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl (KD) is trending due to the abrupt departures of its CFO and General Counsel amid an ongoing accounting review, delayed SEC filings, and internal control weaknesses, which has the community intensely debating severe credibility risks and drawing comparisons to other companies that faced similar financial reporting challenges.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Polyrizon (PLRZ) gained 6% in premarket trading on Tuesday after the company announced that it recently signed a memorandum of understanding to acquire a 51% stake in global private aviation firm Arrow Aviation through a cash investment of NIS 18 million ($5.8 million).Arrow Aviation provides private flights to the public sector, with specialized operations including air ambulances, medical evacuations, rescue missions, special-needs transport, medical tourism, and cargo services, including the transport of sensitive and hazardous materials under special licenses.“We believe that this strategic move, upon completion, represents an exciting diversification opportunity for Polyrizon, allowing us to leverage our strong financial position to enter the dynamic private aviation market, a market set to grow to $41.38 billion by 2030, through a potential acquisition of a high-growth, high-potential company,” said Tomer Izraeli, CEO of Polyrizon.$1 = NIS 3.1Read updates to this developing story on Stocktwits.For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising chart and reflection of business buildings: stock photo courtesy of Yuichiro Chino via Getty Images

PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business?

The company announced that it recently signed an MoU to acquire a 51% stake in private aviation firm Arrow Aviation for around $5.8 million.

Equity

Oscar Health (OSCR) shares rebounded from early losses to rise more than 5% in pre-market trading on Tuesday after the company projected fiscal 2026 revenue well above the FY2025 level reported alongside its fourth-quarter results.Q4 total revenue came in at $2.81 billion, significantly below the Street estimates of $3.12 billion, according to Fiscal.ai data. The company reported a loss of $1.24 per share, wider than the estimates of a loss of $0.92 per share.The company expects fiscal 2026 revenue to be between $18.7 billion and $19 billion, compared with $11.70 billion in fiscal 2025. Oscar Health also expects earnings from operations between $250 and $450 million in FY2026.Read updates to this developing story on Stocktwits.For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the logo of Oscar Health, Inc. is displayed on a smartphone screen on May 04, 2025, in Chongqing, China.  (Photo illustration by Cheng Xin/Getty Images)

Why Did OSCR Stock Gain Pre-Market After Earnings?

The company expects fiscal 2026 revenue to be between $18.7 billion and $19 billion, compared with $11.70 billion in fiscal 2025.

<ul class="summary-bullets"><li>The strategic review could include partnerships, joint ventures, mergers, acquisitions, licensing deals, or other transactions, according to Quince Therapeutics.</li><li>On January 29, QNCX shares plunged 91.5% after the company said it would halt clinical development of its lead asset Edsp.</li><li>Lucid Capital double-downgraded Quince Therapeutics to ‘Sell’ from ‘Buy’ late last month.</li></ul>Shares of Quince Therapeutics, Inc. (QNCX) surged nearly 60% in pre-market trading on Tuesday after the company announced that it has appointed LifeSci Capital as its exclusive financial advisor to support a restructuring effort and review strategic alternatives.The strategic review could include partnerships, joint ventures, mergers, acquisitions, licensing deals, or other transactions, according to the company. In addition to assessing these opportunities, LifeSci Capital will advise Quince Therapeutics on any potential restructuring of its liabilities.Quince, a late-stage biotechnology firm focusing on rare disease treatments, added that it will not provide updates during the review and will disclose developments only if its board approves a specific action or deems further communication necessary.<h2 class="st-heading-2">96% Market Value Erased In Just Over A Week</h2>Quince Therapeutics’ stock has been under heavy selling pressure lately. On January 29, QNCX shares plunged 91.5% after the company <a href="https://stocktwits.com/news-articles/markets/equity/qncx-stock-plummets-over-90-percent/cmyipqPR410">said</a> it would halt clinical development of its lead asset, dexamethasone sodium phosphate encapsulated in autologous erythrocytes (eDSP).The late-stage trial in 105 patients with Ataxia-Telangiectasia, a rare and inherited neurodegenerative disorder, did not meet statistical significance for its primary endpoint. The study also missed its key secondary goal. The stock declined a further 37% in the following session.<a href="https://stocktwits.com/symbol/QNCX">QNCX shares</a> have declined nearly 96% from January 28 to Monday’s close.<h2 class="st-heading-2">Wall Street Turns Bearish</h2>The results prompted Lucid Capital to double downgrade Quince Therapeutics to ‘Sell’ from ‘Buy’ with a price target of $0, down from $8. The firm noted that the program, which is Quince’s asset, will be discontinued, and, given that the company’s estimated cash and long-term debt are nearly equal, it sees no value in the shares.The company has also faced mounting financial pressure. In the third quarter of fiscal 2025, Quince reported a net loss of $13.3 million, more than quadrupling the $3.2 million loss from a year earlier. Total operating expenses jumped 130% to $13.4 million.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, amid ‘extremely high’ message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/QNCX_jpg_46df9654d8.webp" alt="QNCX.jpg" width="927" height="111"><figcaption>QNCX's Sentiment Meter and Message Volumes at Premarket on Feb. 10, 2026 | Source: Stocktwits</figcaption></figure>One bullish user noted the high volumes in after-market trading.<stembedurl>https://stocktwits.com/Risley/message/644527590</stembedurl>However, one bearish user highlighted the company’s shortcomings in the clinical trial.<stembedurl>https://stocktwits.com/Marceltrade/message/644532523</stembedurl>Over the past year, the stock has slumped 91%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/nasdaq-sp500-futures-subdued-tsla-rblx-tsm-hood-kd-stocks-to-watch/cZbUbhPR4Y9">Nasdaq, S&amp;P 500 Futures Subdued After Dow Closes Above 50,000: Why TSLA, RBLX, TSM, HOOD, KD Are On Traders' Radar Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

Why Is QNCX Stock Up 60% Pre-Market After A Near-Total Wipeout?

The company announced that it has appointed LifeSci Capital as its exclusive financial advisor to support a restructuring effort and review strategic alternatives.

This Nano-Cap Biotech Stock Soars 60% Pre-Market Just Days After A Near-Total Wipeout – Here’s What’s Driving The Move

<ul class="summary-bullets"><li>March natural gas futures at Henry Hub were down over 7% to about $3.18 per MMBtu.</li><li>On Friday, U.S. natural gas futures snapped a three-day rally after Baker Hughes reported increased drilling in the Haynesville shale</li><li>ProShares Ultra Bloomberg Natural Gas (BOIL) ETF slid about 14%.</li></ul>U.S. natural gas fell for a second straight session as forecasts called for warmer weather across much of the country, potentially reducing demand for heating fuel.With the recent cold wave in the Northeast fading, temperatures are projected to remain above normal in the Midwest and Southern U.S. through February 18, according to a Bloomberg report on Monday, citing the Commodity Weather Group.<h2 class="st-heading-2">Natural Gas Futures Decline</h2>March natural gas futures at Henry Hub were down over 7% to about $3.18 per million British thermal units (MMBtu) at the time of writing, to their lowest levels since January 16.&nbsp;Contracts maturing in April were down 5.6% at $3.08&nbsp;per MMBtu.On Friday, U.S. natural gas futures snapped a three-day rally after Baker Hughes reported increased drilling in the Haynesville shale. The rig count rose by seven to 50, lifting the total U.S. gas rig count to 130 from 125. More drilling typically signals higher future supply, which can weigh on prices.The reversal follows a late-January rally that pushed gas prices to over three-year highs as Winter Storm Fern triggered power outages, production shutdowns, and tighter pipeline flows, especially along the Eastern Seaboard.<h2 class="st-heading-2">ETF Watch</h2>The sharp decline lifted ProShares UltraShort Bloomberg Natural Gas (<a href="https://stocktwits.com/symbol/KOLD">KOLD</a>), an ETF designed to profit from falling gas prices, by more than 13% on Monday.<figure class="image"><img src="https://news.stocktwits-cdn.com/KOLD_jpg_8da4065ecb.webp" alt="KOLD.jpg" width="922" height="97"><figcaption>KOLD's Sentiment Meter and Message Volumes on Feb. 9, 2026 | Source: Stocktwits</figcaption></figure>However, retail sentiment on Stocktwits regarding the ETF turned ‘bearish’ from ‘extremely bullish’ the day before.One user highlighted a resistance at $27. KOLD is currently trading at around $21.<stembedurl>https://stocktwits.com/Good2go/message/644470008</stembedurl>Conversely, ProShares Ultra Bloomberg Natural Gas (<a href="https://stocktwits.com/symbol/BOIL">BOIL</a>) ETF slid about 14%, with investor sentiment on the platform turning ‘bearish’ from ‘bullish’ a day earlier.KOLD is down about 43% so far in 2026, while BOIL has shed just over 13%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/kd-stock-slumps-amid-third-quarter-updates-cfo-change/cZbvd8OR4o0">KD Stock Sinks 55% To Over 3-Year Lows – What Triggered This Selloff?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Guernsey Power Station, a gas-fired power station in eastern Ohio.

US Natural Gas Futures Decline To Over 3-Week Lows – KOLD Gains 13%

Temperatures are projected to remain above normal in the Midwest and Southern U.S. through February 18, according to a Bloomberg report citing the Commodity Weather Group.

<ul class="summary-bullets"><li>Kyndryl Holdings stated that its audit committee is reviewing cash management, disclosures, and internal financial controls, following voluntary document requests from the SEC.</li><li>The firm expects to report material weaknesses in internal financial controls for the upcoming quarter, fiscal 2025, and the first two quarters of fiscal 2026.</li><li>It expects fiscal 2026 adjusted pretax income between $575 million and $600 million, below an earlier guidance of at least $725 million.</li></ul>Kyndryl Holdings Inc (KD) stock plummeted 55% on Monday to its lowest level in over three years, after the company reported a series of updates, including the departure of its CFO and delays in certain regulatory filings, alongside a lowered financial guidance for fiscal 2026.Trading in the stock was halted twice after the opening bell.<h2 class="st-heading-2">CFO Departs Amid Audit Committee Review</h2>Kyndryl said David Wyshner has stepped down as CFO and Edward Sebold has left his role as general counsel, both effective immediately. Wyshner has been replaced by Harsh Chugh, who has been named as interim CFO. Mark Ringes has been named Interim General Counsel.In a separate release, the company said that its Audit Committee is reviewing cash management, disclosures, and internal financial controls, following voluntary document requests from the Division of Enforcement of the Securities and Exchange Commission (SEC). As a result, Kyndryl said it needs more time to complete its evaluation, which will delay the filing of its Form 10-Q.Kyndryl said it expects to report material weaknesses in its internal control over financial reporting in the upcoming quarterly report, as well as for fiscal year 2025 and the first two quarters of fiscal 2026.<h2 class="st-heading-2">Kyndryl&nbsp;Cuts FY2026 Earnings Guidance</h2>Kyndryl expects fiscal 2026 adjusted pretax income between $575 million and $600 million, significantly below its previous guidance of at least $725 million. The company also cut its earnings before interest, tax, depreciation, and amortization (EBITDA) margin to 17.5% from 18%. The company now expects a 2% to 3% decline in constant-currency revenue, compared to 1% growth it had forecast earlier.While third-quarter (Q3) revenue came in at $3.86 billion, marginally below Wall Street’s $3.89 billion estimate, according to Fiscal.ai data, its earnings of $0.25 per share were less than half the Street's $0.67 per share estimate.Oppenheimer downgraded Kyndryl to “Perform” from “Outperform” and removed its prior price target, according to The Fly. Analyst Ian Zaffino added that Wyshner’s departure creates uncertainty.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday slump, retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘extremely high’ message volumes. <a href="https://stocktwits.com/symbol/KD">KD</a> was among the top trending tickers at the time of writing.<img src="https://news.stocktwits-cdn.com/KD_jpg_d5653784f9.webp" alt="KD.jpg">One user noted the company’s positive cash flow and called the selloff a “huge overreaction.”<stembedurl>https://stocktwits.com/tothattila/message/644440704</stembedurl>The stock has shed more than 60% of its value so far in 2026.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-vzla-stock-slump-today/cZbv2wsR4oQ">Vizsla Silver Issues Update On Abducted Employees In Mexico – VZLA Stock Down 14%</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Information technology infrastructure provider Kyndryl (USA) booth at Tokyo Rainbow Parade 2023. (Photo by Stanislav Kogiku/SOPA Images/LightRocket via Getty Images)

KD Stock Sinks 55% To Over 3-Year Lows – What Triggered This Selloff?

The company announced the departure of its CFO, delays in certain regulatory filings, and a lowered fiscal 2026 outlook.

<ul class="summary-bullets"><li>The company added that it is awaiting official confirmation from Mexican authorities.</li><li>On January 28, Vizsla reported that 10 individuals were taken from its project site in Concordia, prompting a temporary suspension of certain activities.</li><li>Mexican authorities reportedly found bodies near El Verde in Sinaloa during the search for 10 abducted Vizsla mine workers, with one believed to match a missing employee.</li></ul>Vizsla Silver Corp. (VZLA), on Monday, announced that families have informed the company that several employees abducted from its Concordia, Mexico project site have been found deceased. The company added that it is awaiting official confirmation from Mexican authorities and will share updates as they become available.<a href="https://stocktwits.com/symbol/VZLA">VZLA shares</a> traded 14% lower at the time of writing on Monday morning.“We are devastated by this outcome and the tragic loss of life. Our deepest condolences are with our colleagues' families, friends and co-workers, and the entire community of Concordia. Our focus remains on the safe recovery of those who remain missing and on supporting all affected families and our people during this incredibly difficult time,” said Michael Konnert, President &amp; CEO of Vizsla.On January 28, Vizsla Silver <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://vizslasilvercorp.com/vizsla-silver-provides-an-update-on-media-reportedsecurity-incident-at-the-panuco-project/">reported</a> that 10 individuals were taken from its project site in Concordia, prompting a temporary suspension of certain activities at the site.<h2 class="st-heading-2">What Is Known So Far?</h2>According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://abcnews.go.com/International/wireStory/bodies-found-area-mexico-search-10-missing-workers-129940368">report by ABC News</a> last Friday, Mexican authorities discovered bodies and human remains near the rural community of El Verde in Sinaloa state while searching for 10 workers abducted from Vizsla’s mining project.&nbsp;The Attorney General’s Office said one body appears to match the description of a missing employee of Vizsla, though the total number of remains has not been disclosed. Four suspects linked to the disappearances have been arrested, the report read.El Verde is about 15 kilometers north of Concordia, where the kidnapping reportedly occurred. The region has been gripped by escalating violence tied to an ongoing turf war between rival factions of the Sinaloa cartel, prompting increased troop deployments and a federal search operation, the report said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘extremely bearish’ from ‘bearish’ over the past 24 hours.<img src="https://news.stocktwits-cdn.com/VZLA_jpg_4074207f2c.webp" alt="VZLA.jpg">The stock has fallen more than 28% so far in 2026.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/transocean-valaris-merger-val-stock-gains-rig-stock-slumps/cZbH6HiR4od">Transocean, Valaris To Form $17 Billion Offshore Drilling Firm – VAL Stock Jumps 13%, RIG Slumps 6% In Pre-Market</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Trending stocks chart. (Image Courtesy: Getty Images)

Vizsla Silver Issues Update On Abducted Employees In Mexico – VZLA Stock Down 14%

Vizsla Silver Corp. announced that families have informed the company that several employees abducted from its Concordia, Mexico project site have been found deceased.

<ul class="summary-bullets"><li>Transocean shareholders will own around 53% of the new entity, while Valaris investors will hold the remaining 47%.</li><li>The deal is expected to close in the second half of 2026.</li><li>The board of the combined firm will include nine existing Transocean directors and two from Valaris.</li></ul>Transocean Ltd. (RIG) announced on Monday that it has signed an agreement to acquire Valaris (VAL) in an all-stock transaction valued at about $5.8 billion. The deal will create a combined company with an enterprise value of roughly $17 billion.<a href="https://stocktwits.com/symbol/RIG">RIG stock</a> was down around 3% in pre-market trading while&nbsp;<a href="https://stocktwits.com/symbol/VAL">VAL shares</a> jumped more than 21%.<h2 class="st-heading-2">Terms Of The Agreement</h2>Upon completion, Transocean shareholders will own around 53% of the new entity, while Valaris investors will hold the remaining 47%. Valaris shareholders will receive a fixed exchange ratio of 15.235 Transocean shares for each Valaris share.The deal is expected to close in the second half of 2026, after which Keelan Adamson will become the chief executive officer of the merged company, and Jeremy Thigpen will serve as executive chairman.The board will include nine existing Transocean directors and two from Valaris, while the company will stay incorporated in Switzerland and maintain its main administrative office in Houston.<h2 class="st-heading-2">Details Of The Merged Firm</h2>The merger will establish an offshore drilling firm with a fleet of 73 rigs, including ultra-deepwater drillships, semisubmersibles, and modern jackups. According to Valaris’ latest fleet status report, its contract backlog is around $4.5 billion as of Oct. 23, 2025.“We have identified more than $200 million in cost synergies that will complement our ongoing efforts to safely lower costs. The strong pro forma cash flow enables us to accelerate debt reduction, resulting in an expected leverage ratio of about 1.5x within 24 months of the transaction closing,” said Keelan Adamson, Transocean President and Chief Executive Officer.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for VAL on Stoktwits turned ‘bullish’ from ‘neutral’ a day earlier, amid ‘high’ message volumes, while sentiment for RIG remained ‘bullish’ over the past 24 hours. RIG was also among the top trending tickers on the platform at the time of writing.<figure class="image"><img src="https://news.stocktwits-cdn.com/RIG_jpg_6117040f08.webp" alt="RIG.jpg" width="931" height="105"><figcaption>RIG's Sentiment Meter and Message Volumes at Premarket on Feb. 9, 2026 | Source: Stocktwits</figcaption></figure><figure class="image"><img src="https://news.stocktwits-cdn.com/VAL_jpg_8cfcd1aa07.webp" alt="VAL.jpg" width="924" height="100"><figcaption>VAL's Sentiment Meter and Message Volumes at Premarket on Feb. 9, 2026 | Source: Stocktwits</figcaption></figure>One user said the deal reduces RIG’s debt and essentially enables a monopoly.<stembedurl>https://stocktwits.com/Dawgyyyyy/message/644447136</stembedurl>Another user expects RIG’s stock to climb to $8, over 50% upside to its current price of $5.2.<stembedurl>https://stocktwits.com/Sheernonsense/message/644445276</stembedurl>RIG stock has gained nearly 30% so far in 2026, while VAL shares have gained around 24%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-lly-stock-orna-therapeutics-2-4-billion-deal/cZbHzfOR486">LLY Stock Climbs Pre-Market On $2.4 Deal To Acquire Orna Therapeutics</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the Transocean company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Transocean, Valaris To Form $17 Billion Offshore Drilling Firm – VAL Stock Jumps 13%, RIG Slumps 6% In Pre-Market

Transocean announced on Monday that it has signed an agreement to acquire Valaris in an all-stock transaction valued at about $5.8 billion

<ul class="summary-bullets"><li>The company’s FDA-cleared INSPIRA ART100 system is approved for cardiopulmonary bypass in the U.S.&nbsp;</li><li>With this step, ART100 moves from regulatory clearance to active commercial availability, the company said.</li><li>Earlier, Inspira announced a non-binding term sheet for a proposed two-part deal to acquire an advanced liquid biopsy diagnostics business</li></ul>Shares of Inspira Technologies OXY (IINN) popped over 28% in pre-market trading on Monday after Israel’s largest health services provider approved the procurement of its FDA-cleared ART100 platform.<a href="https://stocktwits.com/symbol/IINN">IINN shares</a> gave up premarket gains and fell around 3% after the opening bell.&nbsp;The company secured approval from Clalit Health Services’ Medical Equipment Committee, allowing its INSPIRA ART100 system to be immediately procured and deployed across a healthcare network serving roughly 4.9 million members.<h2 class="st-heading-2">ART100 Regulatory Clearance</h2>With this step, ART100 moves from regulatory clearance to active commercial availability, marking a significant growth opportunity for Inspira and strong clinical validation.“By securing this approval, we are laying the foundation for potentially long-term, high-quality revenue. This validation from a world-class, data-driven health ecosystem serves as a powerful reference case as we accelerate our commercialization efforts in the U.S. and other global markets,” said Dagi Ben-Noon, CEO of Inspira Technologies.The company’s FDA-cleared INSPIRA ART100 system is approved for cardiopulmonary bypass in the U.S. and for (Extracorporeal Membrane Oxygenation) ECMO procedures outside the U.S.<h2 class="st-heading-2">Top U.S. Medical Center Clears ART100&nbsp;</h2>In January, Inspira Technologies’ ART100 system completed clinical evaluation at a top U.S. academic medical centre and moved into the budgeted procurement stage. The system successfully treated about 30 patients across surgeries, transplants, and other critical procedures, leading to its adoption into routine clinical workflows.&nbsp;With the evaluation phase now closed, the hospital has begun an internal process to purchase multiple ART100 units, pending final budget approval.Earlier, Inspira announced a non-binding term sheet for a proposed two-part deal to acquire an advanced liquid biopsy diagnostics business. The transaction also includes a planned $15 million strategic equity investment.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘extremely high’ message volumes.The stock has shed around 25% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

Why Did IINN Stock Surge 28% In Pre-Market Today?

The company won approval from Clalit Health Services to deploy its INSPIRA ART100 system across a network of around 4.9 million members.

<ul class="summary-bullets"><li>Orna’s ORN-252 is a clinical trial-ready CAR-T therapy that targets CD19, a critical cell surface protein to treat B cell-driven autoimmune diseases.</li><li>Early studies indicate Orna’s circular RNA technology could help the body produce therapeutic proteins for a longer period.</li><li>Previously, Orna had tied up with Merck and Vertex Pharmaceuticals.</li></ul>Eli Lilly and Company (LLY) announced on Monday that it has entered into an agreement to acquire Orna Therapeutics, a biotechnology firm focused on cell therapies. Orna shareholders could receive up to $2.4 billion in cash, including upfront and milestone-based payments.&nbsp;<a href="https://stocktwits.com/symbol/LLY">LLY stock</a> was up 1.7% in pre-market trading on Monday.The acquisition will strengthen Lilly’s pipeline with a new class of therapies built on engineered circular RNA and proprietary lipid nanoparticles, enabling the body to generate its own disease-fighting cell therapies.<h2 class="st-heading-2">Orna’s RNA Technology</h2>Orna’s lead candidate, ORN-252, is a clinical trial-ready CAR-T therapy that targets CD19, a critical cell surface protein to treat B-cell-driven autoimmune diseases. Early studies indicate Orna’s circular RNA technology could help the body produce therapeutic proteins for a longer period, potentially enabling treatments not possible with existing RNA or cell therapies.“Early autologous CAR-T studies have shown the promise of cell therapy for patients with autoimmune diseases, but the complexity, cost, and logistics of&nbsp;ex vivo approaches make it challenging to deliver these breakthroughs to the broader population of patients who need them. We look forward to working with Orna colleagues to potentially unlock an entirely new class of genetic medicines and cell therapies for patients who today have limited or no treatment options,” said Francisco Ramírez-Valle, Senior VP, Head of Immunology Research and Early Clinical Development.&nbsp;Orna has previously partnered with major pharmaceutical companies for its RNA technology. In 2022, it teamed up with Merck to develop vaccines and treatments for infectious diseases and cancer, and in January 2025, it launched a three-year research collaboration with Vertex Pharmaceuticals focused on next-generation gene-editing therapies.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for LLY on Stocktwits moderated to ‘bullish’ from ‘extremely bullish’ a day earlier, amid ‘high’ message volumes.<img src="data:image/jpeg;base64,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" width="624" height="72">The stock has remained in the spotlight since the company posted a better-than-expected fourth-quarter report earlier this month, driven by volume growth from Mounjaro and Zepbound for weight loss.Over the past year, the stock has gained more than 26%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-iinn-stock-surge-in-pre-market-today/cZbHzC8R4oP">Why Did IINN Stock Surge 28% In Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. (Photo by Scott Olson/Getty Images)

LLY Stock Climbs Pre-Market On $2.4 Deal To Acquire Orna Therapeutics

The acquisition will strengthen Lilly’s pipeline with a new class of therapies built on engineered circular RNA and proprietary lipid nanoparticles.

LLY Stock Rises As Lilly Bets $2.4 Billion On Next-Gen RNA Cell Therapies 

<ul class="summary-bullets"><li>Ouster funded the deal through roughly $35 million in cash and 1.8 million shares.</li><li>The acquisition will be treated as a business combination, and StereoLabs will operate as a wholly owned unit of Ouster.</li><li>Ouster will become a single-source provider for synchronized lidar and stereo camera data.</li></ul>Ouster, Inc. (OUST) garnered retail traders’ attention in premarket trading on Monday after announcing the completion of the acquisition of AI vision specialist StereoLabs SAS earlier this month.The deal will combine Ouster’s digital lidar with StereoLabs’ advanced camera technology, AI compute, sensor fusion, and perception software to create what Ouster describes as the first end-to-end platform for Physical AI applications.<a href="https://stocktwits.com/symbol/OUST">OUST</a> was among the top trending tickers on Stocktwits at the time of writing, with the stock climbing 2% higher.<h2 class="st-heading-2">StereoLabs Deal Details: Cash, Stock, And 2026 Consolidation</h2>Ouster funded the deal through roughly $35 million in cash and 1.8 million shares, including 0.7 million shares scheduled for release over four years. The acquisition will be treated as a business combination, and StereoLabs will operate as a wholly owned unit of Ouster. StereoLabs’ financial results will be consolidated into Ouster’s statements beginning in the first quarter of fiscal 2026.<h2 class="st-heading-2">StereoLabs Adds Profitable Revenue Stream</h2>StereoLabs generated around $16 million in unaudited revenue in 2025 and brings a positive earnings before interest, tax, depreciation and amortization (EBITDA) business.<h2 class="st-heading-2">New Use Cases: Robotics, Automation, Smart Infrastructure</h2>Ouster will become a single-source provider for synchronized lidar and stereo camera data. The combination is expected to improve software capabilities, expand Ouster’s reach across robotics, industrial automation, and smart infrastructure, and open up emerging use cases such as humanoid robotics and visual inspection.“This acquisition builds on Ouster’s momentum and positions us as the foundational end-to-end sensing and perception platform for Physical AI,” said Ouster CEO Angus Pacala.<h2 class="st-heading-2">Retail Sentiment On Stocktwits Improves</h2>Retail sentiment on Stocktwits flipped to ‘bullish’ from ‘bearish’ a day earlier, amid ‘high’ message volumes.<img src="https://news.stocktwits-cdn.com/Ouster_jpg_3db8985072.webp" alt="Ouster.jpg">One user expects the stock to rise all the way right up to its earnings on March 2.<stembedurl>https://stocktwits.com/Ashtonmar/message/644427184</stembedurl>Year-to-date, the stock has shed around 12%, though its gains over the past year exceed 86%.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/coinbase-super-bowl-ad-backstreet-boys-crypto-mainstream/cZbHwueR48H">Coinbase Super Bowl Commercial Taps Into Backstreet Boys Nostalgia – Marking Crypto’s Cautious Return To Big-Game Ads</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Why Did OUST Stock Catch Retail Attention In Pre-Market Today? 

The company announced that it completed the acquisition of AI vision specialist StereoLabs SAS earlier this month.